For over 170 years, Pfizer has worked to bring breakthroughs that change patients’ lives through medicines, vaccines, and therapeutics around the world. While patients receive treatments in the form of a simple pill or injection, the process of discovering, developing, and manufacturing a drug is incredibly complex. It requires precision research and monitoring, relying heavily on operational data for visibility during the process.
However, for Pfizer’s Small Molecule Division in Groton, Connecticut, operational data was siloed and only available within the physical building, increasing manual work, hindering collaboration and creating data latency issues. To reach its goal of doubling the innovation success rate while decreasing time to market, Pfizer needed a new data strategy. Using OSIsoft’s PI System, Pfizer embarked on a journey to digitize the drug discovery process and create a single source of truth for self-service operational insights that are accessible anytime and anywhere.